The Role of Leukocytes in Diabetic Cardiomyopathy
- PMID: 30443223
- PMCID: PMC6221939
- DOI: 10.3389/fphys.2018.01547
The Role of Leukocytes in Diabetic Cardiomyopathy
Abstract
Diabetes is predominant risk factor for cardiovascular diseases such as myocardial infarction and heart failure. Recently, leukocytes, particularly neutrophils, macrophages, and lymphocytes, have become targets of investigation for their potential role in a number of chronic inflammatory diseases such as diabetes and heart failure. While leukocytes contribute significantly to the progression of diabetes and heart failure individually, understanding their participation in the pathogenesis of diabetic heart failure is much less understood. The present review summarizes the role of leukocytes in the complex interplay between diabetes and heart failure, which is critical to the discovery of new targeted therapies for diabetic cardiomyopathy.
Keywords: diabetes; heart failure; inflammation; leukocyte; lymphocyte.
Figures
Similar articles
-
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.FASEB J. 2017 Oct;31(10):4226-4239. doi: 10.1096/fj.201700109R. Epub 2017 Jun 22. FASEB J. 2017. PMID: 28642328 Free PMC article. Review.
-
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.Int J Cardiol. 2013 Oct 9;168(4):3160-72. doi: 10.1016/j.ijcard.2013.07.150. Epub 2013 Aug 6. Int J Cardiol. 2013. PMID: 23932046 Review.
-
Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.Pharmacol Res. 2019 Aug;146:104295. doi: 10.1016/j.phrs.2019.104295. Epub 2019 Jun 16. Pharmacol Res. 2019. PMID: 31216426 Free PMC article.
-
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.Cardiovasc Res. 2017 Mar 15;113(4):378-388. doi: 10.1093/cvr/cvx011. Cardiovasc Res. 2017. PMID: 28395009 Review.
-
Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.Biomed Rep. 2017 Feb;6(2):140-145. doi: 10.3892/br.2017.841. Epub 2017 Jan 12. Biomed Rep. 2017. PMID: 28357065 Free PMC article.
Cited by
-
Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.Front Endocrinol (Lausanne). 2024 Feb 8;15:1185062. doi: 10.3389/fendo.2024.1185062. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38469146 Free PMC article.
-
MSC exosomes attenuate sterile inflammation and necroptosis associated with TAK1-pJNK-NFKB mediated cardiomyopathy in diabetic ApoE KO mice.Front Immunol. 2024 Feb 8;15:1348043. doi: 10.3389/fimmu.2024.1348043. eCollection 2024. Front Immunol. 2024. PMID: 38390337 Free PMC article.
-
An exploratory human study investigating the influence of type 2 diabetes on macrophage phenotype after myocardial infarction.Int J Cardiol Heart Vasc. 2023 Nov 19;49:101309. doi: 10.1016/j.ijcha.2023.101309. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 38020056 Free PMC article.
-
Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction.Cell Commun Signal. 2023 Oct 30;21(1):298. doi: 10.1186/s12964-022-01016-w. Cell Commun Signal. 2023. PMID: 37904236 Free PMC article. Review.
-
C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation.Cells. 2023 Jan 29;12(3):443. doi: 10.3390/cells12030443. Cells. 2023. PMID: 36766785 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
